JOHNSON & JOHNSON (JNJ) › Cash & EquivalentsJOHNSON & JOHNSON (JNJ) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $4.08B2007: $7.77B2008: $10.77B2010: $15.81B2011: $19.36B2012: $14.91B2013: $20.93B2014: $14.52B2016: $13.73B2017: $17.82B2018: $18.11B2019: $17.30B2021: $13.98B2022: $14.49B2023: $21.86B2024: $24.11B2025: $19.71B$19.71B2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$19.71B-18.2%2024$24.11B+10.3%2023$21.86B+50.9%2022$14.49B+3.6%2021$13.98B—2019$17.30B-4.4%2018$18.11B+1.6%2017$17.82B+29.8%2016$13.73B—2014$14.52B-30.6%2013$20.93B+40.3%2012$14.91B-23.0%2011$19.36B+22.4%2010$15.81B—2008$10.77B+38.6%2007$7.77B+90.3%2006$4.08B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share